​The University of Balamand (UOB), in collaboration with Numelab, has introduced the advanced QIAcuity Digital PCR (dPCR) system, marking a significant step forward in research and diagnostic capabilities. This important step follows a successful first-of-its-kind demonstration of the system at the University, conducted in partnership with Numelab, the official distributor of QIAGEN in Lebanon, highlighting the importance of integrating global technologies within local research environments.

This achievement was made possible through the dedication and leadership of Dr. Mira El Chaar, whose work in microbial research demonstrates the system’s high sensitivity in detecting and quantifying microbial targets while supporting pre-sequencing quality control, Dr. Lara Haddad, and Dr. Maysam Moussa, whose collaborative work in oncology highlights the system’s potential in detecting low-frequency genetic variations and analyzing gene expression at the molecular level. Their contributions highlight the strength of UOB’s academic, research community, and its ongoing efforts to drive impactful research across multiple disciplines.

The successful demonstration showcased the capabilities of the QIAcuity Digital PCR (dPCR) system as an advanced tool in molecular biology and diagnostics, reinforcing a shared commitment to elevating research standards and empowering Lebanese laboratories with world-class technologies.

In microbial research, the platform plays a key role in pathogen detection and pre-sequencing quality control before next-generation sequencing (NGS), enabling the identification of low-abundance targets often missed by conventional methods. This helps reduce unnecessary sequencing and lowers overall research costs.

In oncology, the system demonstrates strong potential in applications requiring the detection of low-frequency genetic variations, including copy number variations at the DNA level and gene expression analysis at the RNA transcriptional level. Its nanoplates technology enhances accuracy in biomarker analysis, supporting more robust translational research outcomes.

This cutting-edge technology enables highly precise and sensitive molecular analysis, supporting innovation in fields such as medical diagnostics, genetics, and biomedical research. 

The initiative reflects UOB’s commitment to strengthening scientific excellence, fostering industry partnerships, and equipping researchers and students with tools to address emerging health and scientific challenges.